福元医药
(601089)
| 流通市值：119.33亿 | | | 总市值：119.33亿 |
| 流通股本：4.80亿 | | | 总股本：4.80亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,520,605,126.57 | 1,633,971,250.02 | 830,471,781.49 | 3,445,642,486.39 |
| 营业收入 | 2,520,605,126.57 | 1,633,971,250.02 | 830,471,781.49 | 3,445,642,486.39 |
| 二、营业总成本 | 2,120,432,691.61 | 1,345,375,722.9 | 698,838,652.84 | 2,942,075,836.89 |
| 营业成本 | 858,150,245.81 | 547,546,114.03 | 277,010,538.45 | 1,133,990,086.45 |
| 税金及附加 | 28,149,405.85 | 18,678,286.14 | 8,000,488.64 | 33,917,505.12 |
| 销售费用 | 852,042,091.19 | 548,468,828.83 | 305,932,114.23 | 1,256,108,201.94 |
| 管理费用 | 109,700,862.91 | 69,310,070.02 | 35,622,099.52 | 135,909,600.14 |
| 研发费用 | 276,839,281.61 | 165,691,773.89 | 74,193,792.66 | 417,370,397.1 |
| 财务费用 | -4,449,195.76 | -4,319,350.01 | -1,920,380.66 | -35,219,953.86 |
| 其中:利息费用 | 1,269,503.11 | 939,165.49 | 519,885.21 | 3,503,320.64 |
| 其中:利息收入 | 5,809,443.96 | 5,250,418.46 | 2,432,737.61 | 38,483,474.83 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 15,559,343.77 | 12,989,935.7 | 8,751,677.53 | 10,767,760.71 |
| 资产处置收益 | 217,888.5 | -35,004.55 | -17,127.83 | 1,037,530.39 |
| 资产减值损失(新) | -5,395,963.39 | -4,085,112.27 | -747,017.2 | -10,682,920.78 |
| 信用减值损失(新) | -1,058,878.15 | -566,309.52 | -256,947.86 | -1,317,605.33 |
| 其他收益 | 13,153,417.64 | 8,797,559.28 | 5,060,086.74 | 39,157,193.39 |
| 四、营业利润 | 422,648,243.33 | 305,696,595.76 | 144,423,800.03 | 542,528,607.88 |
| 加:营业外收入 | 909,160.47 | 731,479.2 | 209,312.69 | 2,545,516.39 |
| 减:营业外支出 | 5,693,975.46 | 4,910,008.82 | 310,061.66 | 4,958,926.35 |
| 五、利润总额 | 417,863,428.34 | 301,518,066.14 | 144,323,051.06 | 540,115,197.92 |
| 减:所得税费用 | 40,073,476.09 | 33,045,980.6 | 13,517,646.32 | 48,037,599.53 |
| 六、净利润 | 377,789,952.25 | 268,472,085.54 | 130,805,404.74 | 492,077,598.39 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 377,789,952.25 | 268,472,085.54 | 130,805,404.74 | 492,077,598.39 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 375,340,383.05 | 267,867,639.64 | 130,633,035.22 | 488,674,918.14 |
| 少数股东损益 | 2,449,569.2 | 604,445.9 | 172,369.52 | 3,402,680.25 |
| 扣除非经常损益后的净利润 | 361,821,020.81 | 258,234,147.69 | 122,127,208.36 | 459,574,069.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.78 | 0.56 | 0.27 | 1.04 |
| (二)稀释每股收益 | 0.78 | 0.56 | 0.27 | 1.04 |
| 九、综合收益总额 | 377,789,952.25 | 268,472,085.54 | 130,805,404.74 | 492,077,598.39 |
| 归属于母公司股东的综合收益总额 | 375,340,383.05 | 267,867,639.64 | 130,633,035.22 | 488,674,918.14 |
| 归属于少数股东的综合收益总额 | 2,449,569.2 | 604,445.9 | 172,369.52 | 3,402,680.25 |
| 公告日期 | 2025-10-30 | 2025-08-19 | 2025-04-30 | 2025-04-01 |
| 审计意见(境内) | | | | 标准无保留意见 |